Skip to main content
Equibles

AQR CAPITAL MANAGEMENT LLC

Position in IDYA — IDEAYA Biosciences, Inc.

CIK 1167557 Greenwich, CT
Back to IDYA Full portfolio

Position in IDYA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,533,462
+$1,128,595 QoQ
Shares Held
67,976
+61.2% QoQ
Ownership
0.070%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#96
of 286 holders
Holding Since
Dec 2020
16 quarters on record
Voting authority Sole 98% Shared 0% None 2%

Common Shares in IDYA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

AQR CAPITAL MANAGEMENT LLC holds $5,658,888,286 across 216 Biotechnology names. IDYA ranks #116 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 1,126,080 $702,155,918
2 INCY
Incyte Corp
 5,320,901 $603,177,333
3 EXEL
Exelixis, Inc.
 11,023,943 $599,812,735
4 JAZZ
Jazz Pharmaceuticals plc
 1,522,568 $366,893,205
5 BMRN
Biomarin Pharmaceutical Inc
 5,699,541 $326,127,732
6 VRTX
Vertex Pharmaceuticals Inc / Ma
 616,170 $306,070,117
7 RVMD
Revolution Medicines, Inc.
 1,295,450 $242,611,869
8 RPRX
Royalty Pharma plc
 4,305,412 $241,404,446

All Filings in IDYA

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,533,462 67,976
2026-03-31 $1,404,867 42,163
2025-12-31 $2,356,876 68,177
2025-09-30 $604,767 22,226
2025-06-30 $427,943 20,359
2024-12-31 $353,708 13,763
2024-09-30 $499,023 15,752
2024-06-30 $548,839 15,632
2024-03-31 $741,395 16,896
2023-12-31 $564,974 15,879
2023-09-30 $460,926 17,084
2023-06-30 $293,961 12,509
2021-12-31 $291,623 12,336
2021-06-30 $521,664 24,853
2021-03-31 $730,051 31,066
2020-12-31 $545,426 38,959